Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2014

Oct 20, 2014

32853_dirs_2014-10-20_21035f35-ccda-4fb7-bd18-535c4f703cbe.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2014-10-16

Reporting Person: Worthington Gajus Vincent (Director, PRESIDENT & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-10-16 Common Stock S 5159 $25.0061 Disposed 33029 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2366 Direct

Footnotes

F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on November 12, 2013 by the Worthington Family Trust dated March 6, 2007, a trust for the benefit of the Reporting Person and the Reporting Person's spouse, for which the Reporting Person and the Reporting Person's spouse serve as trustees.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.055, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: Shares held directly by the Worthington Family Trust dated March 6, 2007.